发明公开
EP3026432A2 METHOD FOR PREDICTING PATIENT'S RESPONSE TO BIGLYCAN TREATMENT 审中-公开
预测患者对大规模治疗反应的方法

METHOD FOR PREDICTING PATIENT'S RESPONSE TO BIGLYCAN TREATMENT
摘要:
The present discloure provides methods for predicting a patient's response to biglycan therapy for diseases or conditions associated with an abnormal level or activity of biglycan; disorders associated with an unstable cytoplasmic membrane, for example, due to an unstable dystrophin associated protein complex (DAPC); disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation. Examples of such diseases include muscular dystrophies, such as Duchenne's Muscular Dystrophy, Becker's Muscular Dystrophy, neuromuscular disorders and neurological disorders. This application also provides combination therapeutics, such as a biglycan therapeutic and a utrophin therapeutic.
信息查询
0/0